Latest News
Doctors, Legal Experts oppose Lowering Age of Consent
Several doctors, psychologists, rights activists and lawyers on Thursday strongly opposed any move to reduce the age of consent from 18 to 16 years, w...
100 Additional Delhi Hospitals to be added under Ayushman Bharat soon
Delhi Health Minister Dr Pankaj Singh on Thursday announced that the government will add 100 more hospitals under the Ayushman Bharat Pradhan Mantri J...
Legible Prescriptions a Fundamental Right: Punjab and Haryana HC directs doctors to use capital letters
Chandigarh: Observing that legible medical prescriptions and diagnosis form an essential part of a patient’s right to health under Article 21 of the C...
DNB Surgery course soon at Lok Bandhu hospital Lucknow
On this, Dr Arun Tiwari said, "We have received permission from NBEMS to start the new course. The hospital has the required infrastructure and is ful...
Bombay HC Grants Conditional Bail to Pharma Manager in Rs 1.25 Crore Suspected Mephedrone Case
Justice Sanjay Deshmukh ordered Kishor Pawar's (57), in Waluj MIDC release on a ₹50,000 personal bond, with strict instructions not to tamper with evi...
Pharmacy Institutions Failing to Submit Data by Aug 31 to Lose 2025-26 Approval: PCI
The Council noted that despite repeated opportunities, some institutions have failed to provide the required details. As a result, such institutions w...
Sun Pharma Gets CDSCO Panel Nod for Phase IV Trial of Esomeprazole Dual Release Tablets 80 mg
According to the minutes of the 12th/25 SEC (Gastroenterology & Hepatology) meeting held on August 20, 2025, at CDSCO headquarters, the proposal was t...
Doctors, Legal Experts oppose Lowering Age of Consent
100 Additional Delhi Hospitals to be added under Ayushman Bharat soon
Legible Prescriptions a Fundamental Right: Punjab and Haryana HC directs doctors to use capital letters
DNB Surgery course soon at Lok Bandhu hospital Lucknow
Bombay HC Grants Conditional Bail to Pharma Manager in Rs 1.25 Crore Suspected Mephedrone Case
Pharmacy Institutions Failing to Submit Data by Aug 31 to Lose 2025-26 Approval: PCI
Sun Pharma Gets CDSCO Panel Nod for Phase IV Trial of Esomeprazole Dual Release Tablets 80 mg
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago